Xencor, Inc. (XNCR) Offers Encouraging Top-Line Results from XmAb7195 Phase 1a
Tweet Send to a Friend
Xencor, Inc. (NASDAQ: XNCR) reported top-line interim results from a Phase 1a study for XmAb 7195. The data show rapid ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
